Intero Biosystems wants drugmakers to test on mini human intestines, not animals
60-Word AI Digest
Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology.
Key Takeaways
- Intero Biosystems wants drugmakers to test on mini human intestines, not animals
- Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology.
- Click full coverage link below for the complete official dispatch.
Intero Biosystems is selling lab-grown human intestines to drugmakers as regulators push for alternatives to animal testing, while the startup looks to scale production and expand its organoid technology.
Original Publisher Attribution
This summary was curated from TechCrunch.